Nivolumab and pembrolizumab as immune-modulating monoclonal antibodies targeting the PD-1 receptor to treat melanoma
| Image |  |
|---|---|
| Description | scientific article published on 30 July 2015 |
| Author/s |
author: Mohammad Abdollahi Elnaz Faghfuri |
| Publication date | July 30, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |